Indian-Origin Blood Cancer Survivor Meets Her Blood Stem Cell Donor

Are you healthy and between 18-50 years? Then, you can register as a blood stem cell donor and give hope to patients waiting for a matching donor.

Indian-origin blood cancer survivor from Kuwait met her blood stem cell donor for the first time virtually, as she gave her a second chance at life.

Sheeja, 38, a nurse in Kuwait suffered from Chronic Myeloid Leukemia, a form of blood cancer. She needed a blood stem cell transplant to survive.

Plasma Therapy Boosts Survival in Covid Patients With Blood Cancers, Reveals Study
Among blood cancer patients hospitalized with coronavirus, administering convalescent plasma from recovered COVID-19 patients dramatically improves likelihood of survival, stated a new study.

‘Register yourself as a blood stem cell donor now and give hope to those patients waiting for a matching donor.’

Suneel Narayan, a 34-year-old finance professional from Bengaluru had, in 2018, registered himself as a potential blood stem cell donor with non-profit organization DKMS BMST Foundation India, dedicated to the fight against blood cancer and blood disorders, such as Thalassemia and Aplastic anemia.

He donated his blood stem cells and gave Sheeja a second chance at life.

"When I got the call saying I came as a match for a patient, I was surprised. My little contribution, which only took a few hours of my effort, had such a big impact on my recipient. And today, even though it was through a virtual medium, I felt so proud to see her healthy and doing well," Suneel said.

How to Avoid Graft-versus-host Disease in Blood Cancer Treatment?
A new drug combination may improve stem cell transplantation from family members in blood cancer treatment.

"I hope that more individuals would register as potential lifesavers and help patients who are battling blood cancer," he added.

February 4 is marked as World Cancer day every year to spread awareness about the disease and its increasing burden.

Oral Blood Cancer Drug Linked to Metabolic Effects: Study
Oral cancer drug ruxolitinib, a Janus kinases (JAK) 1/2 inhibitor, an enzyme-blocker that affects blood cell production found to produce weight gain among users.

In India, every year, over one lakh people are diagnosed with a form of blood cancer and it remains one of the leading causes of cancer-related deaths among children.

"Most people are unaware that a life-threatening disease like blood cancer can be treated and often, a stem cell transplant is the patient's only chance at survival. Stem cell registries like DKMS-BMST recruits voluntary donors and helps thousands of patients like Sheeja who require lifesaving stem cell transplant," said Dr. Biju George, Professor & Head, Department of Hematology, CMC Vellore, who treated Sheeja.

Poor Immune Response in Many Double-vaccinated Blood Cancer Patients: Study
A new research has revealed that more than 50% of double vaccinated blood cancer patients have been left with little protection against COVID-19.

"We felt helpless when Sheeja was diagnosed with blood cancer. There are no words to express our gratitude to Suneel for saving my wife's life; we wish him all the best in his future endeavors," said Sheeja's husband John.

Healthy individuals between 18-50 years of age can register as blood stem cell donors at dkms-bmst.org/register and give hope to patients waiting for a matching donor.

Source-IANS